经海纬象成功完成B轮融资，加速生物基材料合成应用

Core Viewpoint - The article discusses the recent financing of Shanghai Jinghai Weixiang Biological Materials Co., Ltd., which aims to leverage biomanufacturing technology to build a green and low-carbon supercell factory, focusing on PLA (polylactic acid) as its core product [2][3]. Financing and Growth - Jinghai Weixiang completed nearly 100 million yuan in B-round financing, led by Jiazhih Fund, which will support core technology development, capacity expansion, and market growth [2][4]. - The company is preparing for a B+ round of financing to further enhance its growth trajectory [2]. Technological Advancements - The company has developed several internationally leading technologies in the biobased materials production chain, including "non-grain biomass utilization," "new generation industrial strains," "gypsum-free lactic acid technology," and "rPLA recycling" [3]. - The gypsum-free lactic acid technology addresses environmental issues by eliminating gypsum waste during production, enabling cleaner and lower-cost lactic acid production [3]. - The rPLA recycling process allows for the recycling of polylactic acid (PLA), reducing production costs and creating a closed-loop lifecycle for PLA products [3]. Product Applications - PLA, the company's core product, is a high-performance biodegradable material with excellent biocompatibility, degradability, and processing capabilities, widely used in various sectors such as fast-moving consumer goods, food and beverage, agriculture, 3D printing, textiles, biomedicine, and high-end manufacturing [3]. - The integrated production system enables the company to control the entire process from raw material supply to biobased material production and recycling, ensuring product quality and cost advantages [3]. Market Position and Future Outlook - The financing will primarily be used for expanding the production capacity of the scale-up base, developing new technologies, and expanding market channels [4]. - The company has achieved significant milestones in the industrialization of biobased materials, with steady growth in production capacity and market share [4]. - The founder and CEO emphasized the importance of this financing round as a milestone in the company's development, highlighting the unprecedented opportunities in the biomanufacturing sector driven by policy and market demand [4]. - The company aims to continue focusing on core technology research and expand its production scale and application scenarios to provide high-quality biobased material products and solutions [4].